Germany · Series A startup

Who invested in ViferaXS

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 2 months ago

Funding summaryUpdated 26 Oct 2026

$14Mraised across 1 round since 2026, from 1 source

Latest round
Series A, $14MSept 2026
Investors
0
See who backed them

The rounds

  1. Sept 2026
    Series A$14M

    No investor was named in the report.

    Source recorded

Founders and team

From ViferaXS's own website: 2 founders, 1 on the team.

Prof. Dr. Juliane WalzCo-Founder and Immunologist / Oncologist
Prof. Hans-Georg RammenseeCo-Founder and Immunologist
  • Sezai TaskinCEO

Quick answers about ViferaXS

How much has ViferaXS raised?

ViferaXS has raised $14M across 1 round since 2026.

When did ViferaXS last raise?

ViferaXS's most recent round was a Series A of $14M in Sept 2026.

What was ViferaXS's biggest round?

Its most recent round, $14M in Sept 2026, is also its largest on record.

What stage is ViferaXS at?

ViferaXS's latest named round is a Series A, in Sept 2026.

Where is ViferaXS based?

ViferaXS is based in Germany.

Companies like ViferaXS

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.